Document is current
Any future updates will be listed below
-
Authors
Otlu, Burçak
Alexandrov, Ludmil B.
-
Funding
Funding for this research was provided by:
National Institute of Environmental Health Sciences (R01ES030993-01A1, R01ES032547-01)
National Cancer Institute (U01CA290479-01, R01CA269919-01)
Cancer Research UK (C98/A24032)
David and Lucile Packard Foundation (Packard Fellowship for Science, Engineering)
- License Information
-
More Information
Article History
Received: 8 January 2024
Accepted: 8 May 2025
First Online: 20 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: LBA is a co-founder, CSO, scientific advisory member, and consultant for io9, has equity, and receives income. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. LBA’s spouse is an employee of Biotheranostics. LBA declares US provisional applications with serial numbers: 63/289,601, 63/269,033, 63/483,237, 63/366,392, 63/412,835, and 63/492,348, as well as an international patent application PCT/US2023/010679 and European patent application with application number EP25305077.7. BO declares no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.
